A dividend yield that surpasses 7.5% from a pharmaceutical sector giant like Pfizer Inc. (NYSE: PFE) certainly catches the eye of income-seeking investors.
Such a substantial return often signals a mature, stable company generously rewarding its shareholders. However, a closer look reveals a complex picture for the New York-based drugmaker.
